DORAVIRINE
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract Absorption, distribution, metabolism and elimination of doravirine (MK-1439), a novel non-nucleoside reverse…
Doravirine is a non-nucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus type 1 (HIV-1…
In Human Immunodeficiency Virus–1 treatment-naive adults, a fixed combination of doravirine/lamivudine/tenofovir disoproxil…
Doravirine is a new HIV-1 non-nucleoside reverse transcriptase inhibitor that has demonstrated a good efficacy and safety profile…
Background and ObjectiveDoravirine is a novel non-nucleoside reverse transcriptase inhibitor being developed for the treatment of…
Background and ObjectiveDoravirine is a novel, next-generation, non-nucleoside reverse transcriptase inhibitor in development for…
ABSTRACT Doravirine (DOR), which is currently in a phase 3 clinical trial, is a novel human immunodeficiency type 1 virus (HIV-1…
ABSTRACT Doravirine is a novel, highly potent, nonnucleoside reverse transcriptase inhibitor that is administered once daily and…
The development of an efficient and robust process for the production of HIV NNRTI doravirine is described. The synthesis…
Background Doravirine is a novel non-nucleoside inhibitor of HIV-1 reverse transcriptase with potent activity against wild-type…